Disturbances along the brain-gut-microbiota axis may significantly contribute to the pathogenesis of neurodegenerative disorders. Alzheimer's disease (AD) is the most frequent cause of dementia characterized by a progressive decline in cognitive function associated with the formation of amyloid beta (Aβ) plaques and neurofibrillary tangles. Alterations in the gut microbiota composition induce increased permeability of the gut barrier and immune activation leading to systemic inflammation, which in turn may impair the blood-brain barrier and promote neuroinflammation, neural injury, and ultimately neurodegeneration. Recently, Aβ has also been recognized as an antimicrobial peptide participating in the innate immune response. However, in the dysregulated state, Aβ may reveal harmful properties. Importantly, bacterial amyloids through molecular mimicry may elicit cross-seeding of misfolding and induce microglial priming. The Aβ seeding and propagation may occur at different levels of the brain-gut-microbiota axis. The potential mechanisms of amyloid spreading include neuron-to-neuron or distal neuron spreading, direct blood-brain barrier crossing or via other cells as astrocytes, fibroblasts, microglia, and immune system cells. A growing body of experimental and clinical data confirms a key role of gut dysbiosis and gut microbiota-host interactions in neurodegeneration. The convergence of gut-derived inflammatory response together with aging and poor diet in the elderly contribute to the pathogenesis of AD. Modification of the gut microbiota composition by food-based therapy or by probiotic supplementation may create new preventive and therapeutic options in AD.
Keywords: Alzheimer disease; Amyloid; Blood-brain barrier; Gastrointestinal microbiome; Inflammation.
Conflict of interest statement
The Gut Microbiota and Alzheimer's Disease.J Alzheimers Dis. 2017;58(1):1-15. doi: 10.3233/JAD-161141. J Alzheimers Dis. 2017. PMID: 28372330 Review.
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.Gut. 2020 Feb;69(2):283-294. doi: 10.1136/gutjnl-2018-317431. Epub 2019 Aug 30. Gut. 2020. PMID: 31471351
Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.Comput Struct Biotechnol J. 2019 Oct 24;17:1309-1317. doi: 10.1016/j.csbj.2019.09.008. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31921396 Free PMC article. Review.
Brain-gut-microbiota axis in Parkinson's disease.World J Gastroenterol. 2015 Oct 7;21(37):10609-20. doi: 10.3748/wjg.v21.i37.10609. World J Gastroenterol. 2015. PMID: 26457021 Free PMC article. Review.
A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.J Alzheimers Dis. 2020;73(3):849-865. doi: 10.3233/JAD-190872. J Alzheimers Dis. 2020. PMID: 31884474
Cited by 22 articles
Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.BMC Pediatr. 2020 Mar 18;20(1):127. doi: 10.1186/s12887-020-02026-8. BMC Pediatr. 2020. PMID: 32188439 Free PMC article.
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2.Oxid Med Cell Longev. 2020 Jan 31;2020:8630275. doi: 10.1155/2020/8630275. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32089785 Free PMC article.
Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials.Aging (Albany NY). 2020 Feb 15;12(4):4010-4039. doi: 10.18632/aging.102810. Epub 2020 Feb 15. Aging (Albany NY). 2020. PMID: 32062613 Free PMC article.
Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration.Front Bioeng Biotechnol. 2020 Jan 10;7:435. doi: 10.3389/fbioe.2019.00435. eCollection 2019. Front Bioeng Biotechnol. 2020. PMID: 31998702 Free PMC article. Review.
Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.PLoS One. 2020 Jan 24;15(1):e0228172. doi: 10.1371/journal.pone.0228172. eCollection 2020. PLoS One. 2020. PMID: 31978130 Free PMC article.